Chitosan Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Global Chitosan Market Analysis and It is Segmented by Source (Shrimps, Prawns, Crabs), Application (Water Treatment, Cosmetics, Pharmaceutical and Biomedical, Food and Beverage, Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The Report Offers the Value (in USD Million) for the Above Segments.

Chitosan Market Size

Chitosan Market
Study Period 2019 - 2029
Market Size (2024) USD 2.06 Billion
Market Size (2029) USD 3.74 Billion
CAGR (2024 - 2029) 12.72 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Chitosan Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Chitosan Market Analysis

The Global Chitosan Market size is estimated at USD 2.06 billion in 2024, and is expected to reach USD 3.74 billion by 2029, growing at a CAGR of 12.72% during the forecast period (2024-2029).

The Global Chitosan Market size is estimated at USD 2.09 billion in 2024, and is expected to reach USD 3.67 billion by 2029, growing at a CAGR of 11.93% during the forecast period (2024-2029).

Globally, researchers are showing interest in the use of chitosan in the pharmaceutical and biomedical fields as a potential agent for the prevention and treatment of infectious diseases. In December 2019, China became the epicenter of the SARS-CoV-2 outbreak, which has since spread internationally. In 2020, the World Health Organization (WHO) declared COVID-19 to be a global health emergency. Countering the impacts of viral disease outbreaks such as COVID-19 required R&D activities by researchers across the globe. Thus, the COVID-19 outbreak is likely to show a positive impact on the market growth as the application of chitosan polymers as viral inhibitors would generate key growth opportunities in the near future.

Furthermore, biopolymers such as chitosan have intrinsic antiviral properties. Nanostructured drug-delivery systems (NDDS)-based carbohydrate-binding agents, such as the sulfated polymers, can also change the virus entry process, blocking the viral cationic surface receptors and avoiding its interaction with heparan sulfate proteoglycan on the host cell surface. However, there are no reports of NDDS as COVID-19 treatment so far. It can be a new approach for COVID-19 treatment in the near future.

The other factors driving the market growth include growing product applications in biomedical, cosmetics, and food and beverage industries, rising water treatment activities worldwide, and strong advancements in the healthcare/medical industry in developed countries.

Chitosan composed systems utilize the characteristics of chitosan to achieve great therapeutic effects. For instance, the adhesiveness of chitosan can be used for non-invasive mucosal vaccine vectors. Therefore, chitosan-composed systems have great potential in the therapy of infectious diseases.

Chitosan is a natural polysaccharide that exhibits properties such as biodegradability, non-toxicity, biocompatibility, hemostatic and bio-adhesiveness, and penetration-enhancing properties. Moreover, it has anti-microbial properties.

As per National Center for Biotechnology Information (NCBI), deacetylated chitosan is a vital additive in filtration and water treatment, which eliminates 99% of turbidity. Moreover, chitosan is an easily available product extracted from a waste product in the fishery industry with several uses in other industries such as wound care material in pharmaceutical industries, acts as a natural flavor, and used to control moisture in food industries leading to the high demand for these polymer and further boost the overall market.

Furthermore, stringent government regulations are forcing manufactures to reduce plastic bags, resulting in the growing demand for biodegradable plastic where chitin is being widely used. This led to the increasing adoption of chitosan and further drive the market growth over the forecast period.

Chitosan Market Trends

Under Application, Water Treatment is Expected to Witness a Healthy Growth Rate Over the Forecast Period

Water treatment is expected to witness healthy growth in the future, attributing to the growing demand for chitosan in industries, commercial, and municipal water treatment plants. Several advantages, such as the ability to remove pesticides, surfactants, and phenol from water, make it highly preferable in water treatment plants. Increasing demand for chitosan as a water cleaner because of its non-toxic, non-allergic biodegradable nature will also be leading to propel the segment growth.

The presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in water and wastewater has recently been reported. The stools and masks of COVID-19 patients were considered as the primary route of coronavirus transmission into water and wastewater.

For instance, according to a research article by Hai Nguyen Tran et al. published in the Environmental Research Journal 2021, the study confirmed that SARS-CoV-2 RNA was detected in inflow wastewater. Although, the existence of SARS-CoV-2 in water influents has been confirmed. Therefore, in the future, studies should focus on the survival of SARS-CoV-2 in water and wastewater under different operational conditions and whether the transmission from COVID-19-contaminated water to humans is an emerging concern. Thus, the use of chitosan for water treatment in the near future is expected to encourage the prevention of viral diseases like COVID-19.

Furthermore, chitosan is a good flocculant for tap water treatment due to properties such as faster deposition rate and higher removal efficiency for COD (organic matter), metal ions, and SS (suspended solids). Moreover, as countries around the globe emphasize wastewater treatment to minimize pollution, chitosan's demand is likely to continue increasing in the coming years.

Depleting groundwater levels and the rapidly growing urban population in the Asia-Pacific countries have resulted in the acute scarcity of usable freshwater. This has led to investments by governments and private players in water treatments, mainly in India, China, and Malaysia.

For instance, in India, during 2012-2017, the Indian planning commission had budgeted around USD 26.5 billion to provide safe water to all urban and rural Indians. Treatment of sewage, wastewater treatment, solid, liquid, and chemical waste, water technology, environmental services, desalination companies, consulting, and engineering are some services that India will require to tackle the water problem.

In addition, in 2019, the Government of India, with the Bhabha Atomic Research Centre (BARC), planned to install water filtration plants in villages. The government targets to provide clean drinking water to everyone by 2024. Thus, owing to the above-mentioned factors, it is expected to drive the segment's growth over the forecast period.

Estimated Wastewater Treatment (in %), by Country, 2018

North America is Expected to Hold a Significant Share in the Market Over the Forecast Period

North America is expected to hold a significant market share in the Global Chitosan Market, due to increasing awareness regarding water treatment and the growing demand for cosmetics in the United States, along with the presence of major players. Furthermore, increasing healthcare expenditure and the presence of well-established healthcare infrastructure are also fueling the growth of the overall regional market to a large extent.

The COVID-19 pandemic has shown a positive response toward the Chitosan Market as chitosan-based research and development has been increasing in the development of therapeutics or protective equipment in the management of the disease. In 2021, clinical studies are being conducted to investigate the protective effect of a new type of respirator with a filter element containing chitosan nanoparticles, which show a positive impact on the market.

Increasing obesity and overweight issues in the region and rising health awareness among people act as significant opportunities for the chitosan market. For instance, obesity is one of the major population health issues in Canada, affecting one in five Canadian adults as per the Canadian Institute for Health Information. Seven million Canadians were living with obesity, according to a 2017 Canadian Obesity Network report.

Asia-Pacific is also expected to grow at a healthy growth in the forecast period due to the rapid development of end-user industries in Japan, China, India, and South Korea. The increasing demand for biobased products, coupled with a supportive government, and initiatives would also boost the chitosan market.

One of the key factors driving the chitosan demand in the Asia-Pacific region is the easy availability of its raw material, obtained as a waste product from the fishery industry. For instance, according to the Food and Agriculture Organization of the United Nations, during the first half of 2019, China imported 285,900 tons of shrimp, mainly from Ecuador, India, and Saudi Arabia, which was 186% more compared to 100,000 tons imported in 2018. Thus, owing to the above-mentioned factors, the market is likely to grow.

Chitosan Market - Growth Rate by Region

Chitosan Industry Overview

The Chitosan Market is fragmented, competitive, and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some companies currently dominating the market include Panvo Organics Pvt Ltd, KitoZyme SA, KIMICA Corporation, Dainichiseika Color & Chemicals Mfg Co. Ltd, Heppe Medical Chitosan GmbH, Meron Biopolymers, and Qingdao Yunzhou.

Chitosan Market Leaders

  1. KitoZyme S.A.

  2. Panvo Organics Pvt., Ltd.

  3. Heppe Medical Chitosan GmbH

  4. KIMICA Corporation

  5. Meron Biopolymers

*Disclaimer: Major Players sorted in no particular order

Chitosan Market Concentration
Need More Details on Market Players and Competitors?
Download PDF

Chitosan Market News

In March 2021, in Brazil, the University of Brasilia, in collaboration with the University of Campinas, Brazil, Centro de Pesquisa em Biotecnologia Ltda, Hospital Regional da Asa Norte (HRAN), Hospital da Região Leste (HRL), and Hospital Universitário de Brasília (HUB/UnB), was conducting VESTA clinical trial to assess the effectiveness of a novel respirator with chitosan nanoparticles to reduce the incidence of SARS-CoV-2 infection in healthcare professionals.

In March 2020, Bioavanta-Bosti, a leader in chitosan nanoparticles research, launched Novochizol, which is a unique chitosan nanoparticle technology that can be used to deliver and confine any potential anti-COVID-19 drug to the lungs of acutely ill patients.

Chitosan Market Report - Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Definition

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Water Treatment Activities

      2. 4.2.2 Growing Product Application in the Biomedical, Cosmetics, and Food and Beverage Industries

      3. 4.2.3 Strong Advancements in the Healthcare/Medical Industry

    3. 4.3 Market Restraints

      1. 4.3.1 Regulatory Framework

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Source

      1. 5.1.1 Shrimps

      2. 5.1.2 Prawns

      3. 5.1.3 Crabs

      4. 5.1.4 Other Sources

    2. 5.2 By Application

      1. 5.2.1 Water treatment

      2. 5.2.2 Cosmetics

      3. 5.2.3 Pharmaceutical and Biomedical

      4. 5.2.4 Food and Beverage

      5. 5.2.5 Other Applications

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Panvo Organics Pvt Ltd

      2. 6.1.2 KitoZyme SA

      3. 6.1.3 KIMICA Corporation

      4. 6.1.4 Dainichiseika Color & Chemicals Mfg Co. Ltd

      5. 6.1.5 Heppe Medical Chitosan GmbH

      6. 6.1.6 Meron Biopolymers

      7. 6.1.7 Qingdao Yunzhou

      8. 6.1.8 ChitoTech

      9. 6.1.9 Marshal Marine

      10. 6.1.10 BIO21 Co. Ltd

      11. 6.1.11 Austanz Chitin Pty Ltd

      12. 6.1.12 KiOmed Pharma

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Chitosan Industry Segmentation

As per the scope of the report, Chitosan is an amino polysaccharide polymer used for various commercial and possible biomedical uses. It is produced from shells of crab, lobster, and shrimp. The Global Chitosan Market is segmented by Source (Shrimps, Prawns, Crabs), Application (Water Treatment, Cosmetics, Pharmaceutical and Biomedical, Food and Beverage, Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The report offers the value (in USD million) for the above segments.

By Source
Shrimps
Prawns
Crabs
Other Sources
By Application
Water treatment
Cosmetics
Pharmaceutical and Biomedical
Food and Beverage
Other Applications
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Chitosan Market Research FAQs

The Global Chitosan Market size is expected to reach USD 2.06 billion in 2024 and grow at a CAGR of 12.72% to reach USD 3.74 billion by 2029.

In 2024, the Global Chitosan Market size is expected to reach USD 2.06 billion.

KitoZyme S.A., Panvo Organics Pvt., Ltd., Heppe Medical Chitosan GmbH, KIMICA Corporation and Meron Biopolymers are the major companies operating in the Global Chitosan Market.

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).

In 2024, the North America accounts for the largest market share in Global Chitosan Market.

In 2023, the Global Chitosan Market size was estimated at USD 1.80 billion. The report covers the Global Chitosan Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Chitosan Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.

Chitosan Industry Report

Statistics for the 2024 Chitosan market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Chitosan analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!

Chitosan Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)